Cargando…
Evolution of COVID-19 Pregnancies Treated With Nitazoxanide in a Third-Level Hospital
Background Nitazoxanide shows adequate in vitro activity against coronavirus. The aim of this study was to describe the behavior of coronavirus disease 2019 (COVID-19) in pregnant women treated with nitazoxanide. Methodology This cross-sectional study included the files of COVID-19 positive pregnant...
Autores principales: | Enríquez López, Krista Yazareth, Meneses Calderón, José, de la Cruz Ávila, Lilia, López Esquivel, Miguel Ángel, Meneses Figueroa, Jazmín, Vargas Contreras, María José, Anaya Herrera, José, Sotelo Martínez, Ofelia Roxana, Mendoza López, José Antonio, Mendieta Zerón, Hugo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196550/ https://www.ncbi.nlm.nih.gov/pubmed/34131543 http://dx.doi.org/10.7759/cureus.15002 |
Ejemplares similares
-
Treatment with Hydroxychloroquine vs Hydroxychloroquine + Nitazoxanide in COVID-19 patients with risk factors for poor prognosis: A structured summary of a study protocol for a randomised controlled trial
por: Calderón, José Meneses, et al.
Publicado: (2020) -
Onset of Spontaneous Ovarian Hyperstimulation Syndrome in the Third Trimester: Case Report
por: Alqurashi, Rawan M, et al.
Publicado: (2022) -
Uterine Dehiscence in the Early Third Trimester: A Report of Two Cases
por: Nalbandyan, Kristina, et al.
Publicado: (2023) -
Endometriosis-Related Spontaneous Hemoperitoneum in the Third Trimester: A Case Report
por: Gomes Pereira, João Pedro, et al.
Publicado: (2022) -
Ruptured Hepatic Hemangioma in the Third Trimester of Pregnancy: A Rare Case Report
por: Ward, Haven, et al.
Publicado: (2022)